Description: The US healthcare system before and after Obamacare – better or worse and what's next?

Description: The article describes medical progress in cancer diagnostics and addresses its implications for Critical Illness Insurance.

Description: Q&A with President Life & Health US. Swiss Re. Neil Sprackling.

Description: An update on HMO market trends and reinsurance products, and services supporting them.

Description: Feature article discussing limited benefit health plans as alternative options to address a national crisis—health care for the working uninsured.

Description: With the medical insurance market experiencing health care inflation of 10 to 13 percent and medical costs averaging above $8,000 per year per employee less for single employees and more for employees with families, employers are looking at alternative options. Politicians and regulators are as well.

Description: The diary of Dirk Nieder, an actuary who traveled in Asia amid the COVID-19 pandemic, tying in what he saw in asia countries and developments from the west.

Description: Managed care networks are important to control rising health care costs . these need to be priced appropriately to produce the right results for all stakeholders . This includes analysis of utilization and costs for both in and out of network claims . A variety of risk and administrative service options exist for entities assuming such risk .

Description: Cell and Gene Therapy (CGT) are life-changing treatments where conditions such as cancer, hemophilia, spinal muscular atrophy and blindness are being cured. These are great for individuals and society, but the treatment costs are expensive which is bad for payers and reinsurers. This article explores ways for health reinsurance actuaries to participate in the space and evaluate the risk associated with these treatments